URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

John Bisognano

Concepts (327)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hypertension
34
1998
307
14.380
Why?
Antihypertensive Agents
21
1998
83
8.680
Why?
Baroreflex
9
2006
22
5.840
Why?
Electric Stimulation Therapy
9
2006
29
5.210
Why?
Blood Pressure
13
2004
468
4.070
Why?
Carotid Sinus
6
2006
11
2.530
Why?
Drug Resistance
6
2006
100
1.790
Why?
Heart Failure
5
1996
360
1.790
Why?
Diuretics
4
2006
34
1.520
Why?
Humans
57
1993
37165
1.460
Why?
Fumarates
3
2008
20
1.440
Why?
Amides
3
2008
40
1.420
Why?
Angiotensin-Converting Enzyme Inhibitors
6
1998
50
1.400
Why?
Treatment Outcome
12
2004
2671
1.350
Why?
Electrodes, Implanted
6
2006
56
1.310
Why?
Renin-Angiotensin System
3
1999
21
1.200
Why?
Electrocardiography
5
2003
746
1.180
Why?
Amlodipine
2
2004
7
1.020
Why?
Hospitalization
2
2007
385
1.010
Why?
Life Style
2
2011
91
0.960
Why?
Angiotensin Receptor Antagonists
2
1998
11
0.930
Why?
Emergency Treatment
2
1999
35
0.880
Why?
Tobacco Use Cessation Products
1
2012
3
0.880
Why?
Acute Coronary Syndrome
1
2012
7
0.870
Why?
Sympathetic Nervous System
2
2006
116
0.850
Why?
Heart Transplantation
2
1999
69
0.840
Why?
Renin
2
2008
60
0.840
Why?
Female
22
1997
20222
0.830
Why?
Male
24
1997
20139
0.830
Why?
Plant Preparations
1
2011
2
0.830
Why?
Patient Care
1
2012
41
0.820
Why?
Implantable Neurostimulators
1
2011
2
0.810
Why?
Heart Neoplasms
2
2008
22
0.810
Why?
Retrospective Studies
9
2004
2302
0.810
Why?
Middle Aged
17
1997
10013
0.810
Why?
Community Health Services
1
2012
80
0.790
Why?
Dietary Supplements
1
2011
46
0.790
Why?
Sympathectomy
1
2011
21
0.790
Why?
Adrenergic beta-Antagonists
2
2007
157
0.790
Why?
Smoking Cessation
1
2012
95
0.780
Why?
Myocardial Ischemia
2
2007
120
0.780
Why?
Lymphoma, Large B-Cell, Diffuse
2
2008
80
0.750
Why?
Arrhythmias, Cardiac
1
2012
237
0.740
Why?
Continuous Positive Airway Pressure
1
2010
8
0.740
Why?
Endocarditis
1
2010
11
0.740
Why?
Mitral Valve Insufficiency
1
2010
21
0.730
Why?
Hypertension, Pregnancy-Induced
1
2009
4
0.730
Why?
Sleep Apnea, Obstructive
1
2010
16
0.720
Why?
Mitral Valve
1
2010
37
0.720
Why?
Hemodynamics
2
2004
269
0.720
Why?
Calcium Channel Blockers
2
2007
69
0.710
Why?
Thromboembolism
1
2010
43
0.710
Why?
Catheter Ablation
1
2011
81
0.710
Why?
Pressoreceptors
1
2009
11
0.700
Why?
Erythema Multiforme
1
2009
3
0.690
Why?
Metoprolol
1
2009
10
0.690
Why?
Quality of Health Care
1
2012
230
0.690
Why?
Circadian Rhythm
1
2009
85
0.670
Why?
Music
1
2009
21
0.670
Why?
Staphylococcus aureus
1
2010
109
0.670
Why?
Diterpenes, Kaurane
1
2008
1
0.660
Why?
Comorbidity
3
2003
377
0.660
Why?
Pregnancy Outcome
1
2009
131
0.650
Why?
Sweetening Agents
1
2008
16
0.650
Why?
Aged
13
1998
7392
0.640
Why?
Deglutition Disorders
1
2008
28
0.630
Why?
Heart Diseases
1
2009
138
0.620
Why?
Smoking
1
2012
423
0.620
Why?
Trans Fatty Acids
1
2007
2
0.610
Why?
Echocardiography
5
1998
217
0.610
Why?
Natriuretic Peptide, Brain
1
2007
11
0.600
Why?
Blood Urea Nitrogen
1
2007
42
0.600
Why?
Drugs, Generic
1
2007
10
0.600
Why?
Cardiac Output, Low
1
2007
16
0.600
Why?
Kidney
1
2011
589
0.600
Why?
Energy Intake
1
2007
62
0.600
Why?
Protein Precursors
1
2007
84
0.570
Why?
Patient Care Planning
1
2007
75
0.570
Why?
Vascular Diseases
1
2007
74
0.570
Why?
Receptors, Endothelin
1
2006
15
0.570
Why?
Health Policy
1
2007
89
0.560
Why?
Coronary Disease
2
2003
257
0.550
Why?
Ailanthus
1
2005
1
0.540
Why?
Leukoaraiosis
1
2005
1
0.540
Why?
Hospital Costs
1
2006
35
0.540
Why?
Myocarditis
1
2005
14
0.540
Why?
Cardiovascular Diseases
2
2004
275
0.530
Why?
Geriatric Assessment
1
2007
168
0.530
Why?
Coronary Vasospasm
1
2005
8
0.530
Why?
Tetrazoles
1
2004
12
0.520
Why?
Peptide Fragments
1
2007
307
0.510
Why?
Myocardium
3
1996
319
0.510
Why?
Valine
1
2004
32
0.510
Why?
Brain Ischemia
1
2005
89
0.490
Why?
Follow-Up Studies
4
2003
1889
0.470
Why?
Emergency Service, Hospital
1
2006
214
0.460
Why?
Drug Therapy, Combination
4
1998
397
0.460
Why?
Stroke
1
2005
138
0.450
Why?
Acute Disease
4
1999
591
0.450
Why?
Myocardial Infarction
2
2003
651
0.440
Why?
Predictive Value of Tests
3
2008
609
0.440
Why?
Adult
11
1997
11572
0.430
Why?
Time Factors
4
2007
3234
0.420
Why?
New York
3
2007
1378
0.410
Why?
Aged, 80 and over
5
1998
2588
0.390
Why?
Receptors, Adrenergic, beta-1
1
2000
1
0.380
Why?
Prognosis
3
2007
1078
0.380
Why?
Randomized Controlled Trials as Topic
3
2004
415
0.360
Why?
Parvovirus B19, Human
1
1999
6
0.360
Why?
Parvoviridae Infections
1
1999
12
0.360
Why?
Europe
2
2007
77
0.350
Why?
Erythropoietin
1
1999
27
0.350
Why?
Proto-Oncogene Proteins c-bcl-2
1
2000
116
0.350
Why?
Hypertension, Malignant
1
1999
6
0.350
Why?
Animals
7
2000
16416
0.340
Why?
Stroke Volume
3
2007
144
0.340
Why?
Immunocompromised Host
1
1999
85
0.340
Why?
Heart
1
2000
239
0.330
Why?
Ventricular Outflow Obstruction
1
1998
10
0.330
Why?
Tricuspid Valve
1
1998
18
0.320
Why?
Exercise
2
2008
181
0.320
Why?
Blood Pressure Monitoring, Ambulatory
2
2007
13
0.310
Why?
Subclavian Artery
1
1997
25
0.310
Why?
Survival Rate
2
2007
619
0.310
Why?
Risk Factors
3
2008
2331
0.310
Why?
Odds Ratio
2
2003
323
0.300
Why?
Double-Blind Method
2
2008
996
0.300
Why?
Biological Markers
3
2000
564
0.290
Why?
Logistic Models
2
2008
626
0.280
Why?
United States
3
2007
2847
0.280
Why?
Michigan
2
2003
19
0.270
Why?
Erythrocytes
2
1993
346
0.260
Why?
Echocardiography, Transesophageal
2
1998
54
0.260
Why?
Angiotensin II Type 1 Receptor Blockers
2
2004
9
0.260
Why?
Length of Stay
2
2006
295
0.250
Why?
Clinical Trials as Topic
2
2007
685
0.250
Why?
Protons
2
1993
81
0.240
Why?
Hydroxides
1
1993
24
0.230
Why?
Labetalol
2
1999
5
0.230
Why?
Emergencies
2
1999
83
0.220
Why?
Feasibility Studies
2
2004
212
0.220
Why?
Electric Power Supplies
1
2012
11
0.210
Why?
Social Marketing
1
2012
10
0.210
Why?
Education
1
2012
41
0.210
Why?
Breathing Exercises
1
2011
3
0.210
Why?
Confidence Intervals
1
2012
164
0.210
Why?
Program Development
1
2012
84
0.200
Why?
Cohort Studies
2
2009
984
0.200
Why?
Cooperative Behavior
1
2012
101
0.190
Why?
Registries
1
2012
218
0.190
Why?
Program Evaluation
1
2012
225
0.190
Why?
Ventricular Function, Left
1
2011
86
0.190
Why?
Severity of Illness Index
2
1999
943
0.190
Why?
Nafcillin
1
2010
2
0.190
Why?
Practice Guidelines as Topic
2
2010
319
0.190
Why?
Rhinitis, Allergic, Perennial
1
2010
6
0.180
Why?
Echocardiography, Doppler, Color
1
2010
13
0.180
Why?
Motivation
1
2012
162
0.180
Why?
Retinal Vessels
1
2010
38
0.180
Why?
Maternal Mortality
1
2009
9
0.180
Why?
Eclampsia
1
2009
8
0.180
Why?
Blood Pressure Determination
1
2009
20
0.180
Why?
Carotid Body
1
2009
10
0.180
Why?
Meta-Analysis as Topic
1
2010
36
0.180
Why?
Pre-Eclampsia
1
2009
25
0.180
Why?
Incidence
1
2012
682
0.180
Why?
Hypersensitivity
1
2010
47
0.180
Why?
Markov Chains
1
2009
40
0.180
Why?
Diastole
1
2009
24
0.180
Why?
Health Promotion
1
2012
170
0.170
Why?
Systole
1
2009
39
0.170
Why?
Prenatal Care
1
2009
69
0.170
Why?
Monitoring, Physiologic
1
2009
110
0.170
Why?
Takotsubo Cardiomyopathy
1
2009
3
0.170
Why?
Heart Atria
1
2009
63
0.170
Why?
Hydroxyzine
1
2009
3
0.170
Why?
Adrenal Cortex Neoplasms
1
2009
12
0.170
Why?
Histamine H1 Antagonists
1
2009
14
0.170
Why?
Coronary Angiography
2
2005
83
0.170
Why?
Periodicity
1
2009
41
0.170
Why?
Pheochromocytoma
1
2009
39
0.170
Why?
Hypotension
1
2009
44
0.170
Why?
Treatment Failure
1
2009
131
0.170
Why?
Drug Evaluation, Preclinical
1
2008
79
0.160
Why?
Chi-Square Distribution
1
2009
347
0.160
Why?
Equipment Design
1
2009
253
0.160
Why?
Proportional Hazards Models
1
2009
426
0.160
Why?
Posture
1
2008
112
0.160
Why?
Placebos
1
2008
185
0.160
Why?
Kidney Diseases
1
2010
170
0.160
Why?
Carotid Arteries
1
2009
106
0.160
Why?
Esophageal Neoplasms
1
2009
133
0.160
Why?
Health Status Indicators
1
2008
112
0.150
Why?
Diet, Fat-Restricted
1
2007
4
0.150
Why?
Diet, Sodium-Restricted
1
2007
13
0.150
Why?
Minoxidil
1
2007
3
0.150
Why?
Combined Modality Therapy
1
2009
491
0.150
Why?
Chlorthalidone
1
2007
5
0.150
Why?
Drug Costs
1
2007
27
0.150
Why?
Hospitals, Special
1
2007
9
0.150
Why?
Body Weight
1
2008
337
0.150
Why?
Sodium Chloride Symporter Inhibitors
1
2007
10
0.150
Why?
Evidence-Based Medicine
1
2009
210
0.150
Why?
Electric Stimulation
1
2007
227
0.150
Why?
Risk Reduction Behavior
1
2007
40
0.150
Why?
Ambulatory Care Facilities
1
2007
35
0.150
Why?
Patient Readmission
1
2007
43
0.150
Why?
Creatinine
1
2007
131
0.150
Why?
Video Games
1
2007
24
0.150
Why?
Receptors, Cell Surface
1
2008
217
0.140
Why?
Diabetes Complications
1
2007
66
0.140
Why?
Patient Admission
1
2007
84
0.140
Why?
Diet
1
2008
212
0.140
Why?
Risk
1
2007
355
0.140
Why?
Captopril
1
2006
14
0.140
Why?
Metabolic Syndrome X
1
2007
61
0.140
Why?
Forecasting
1
2007
188
0.140
Why?
Clonidine
1
2006
34
0.140
Why?
Vasoconstriction
1
2006
41
0.140
Why?
Multivariate Analysis
1
2008
548
0.140
Why?
Asthma
1
2010
314
0.140
Why?
Obesity
1
2010
349
0.140
Why?
Treatment Refusal
1
2006
43
0.140
Why?
Heart Rate
1
2008
457
0.140
Why?
Patient-Centered Care
1
2007
78
0.130
Why?
Patient Compliance
1
2007
177
0.130
Why?
Anti-Bacterial Agents
1
2010
442
0.130
Why?
Nitroglycerin
1
2005
19
0.130
Why?
Magnetic Resonance Imaging
2
2008
1019
0.130
Why?
Nerve Fibers, Myelinated
1
2005
39
0.130
Why?
Risk Assessment
1
2009
875
0.130
Why?
Isoproterenol
1
2004
80
0.130
Why?
Vasodilator Agents
1
2005
77
0.130
Why?
Young Adult
1
2009
1084
0.130
Why?
Adrenergic beta-Agonists
1
2004
54
0.120
Why?
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
2
1993
13
0.120
Why?
Disease Models, Animal
1
2009
974
0.120
Why?
Prevalence
1
2007
582
0.120
Why?
Emergency Medical Services
1
2006
139
0.120
Why?
Graft Rejection
1
2005
144
0.120
Why?
Transplantation, Homologous
1
2005
280
0.120
Why?
Dementia
1
2005
104
0.120
Why?
Fatal Outcome
2
1997
109
0.120
Why?
Pregnancy
1
2009
1941
0.120
Why?
Energy Metabolism
1
2004
137
0.120
Why?
Troponin I
1
2003
6
0.120
Why?
Chlorides
2
1993
131
0.120
Why?
Creatine Kinase
1
2003
56
0.120
Why?
Cardiovascular Agents
1
2003
22
0.120
Why?
Patient Education as Topic
1
2005
227
0.120
Why?
Syndrome
1
2003
209
0.110
Why?
Sex Distribution
1
2003
161
0.110
Why?
Cerebral Cortex
1
2005
257
0.110
Why?
Genetic Predisposition to Disease
1
2005
317
0.110
Why?
Age Distribution
1
2003
227
0.110
Why?
Disease Progression
1
2005
533
0.110
Why?
Reference Values
1
2003
453
0.100
Why?
Regression Analysis
1
2003
539
0.100
Why?
Diagnosis, Differential
2
1997
889
0.100
Why?
Rats
1
2009
4389
0.100
Why?
bcl-2-Associated X Protein
1
2000
55
0.090
Why?
Fenoldopam
1
1999
1
0.090
Why?
Nitroprusside
1
1999
32
0.090
Why?
Injections, Intravenous
1
1999
133
0.080
Why?
Drug Monitoring
1
1999
41
0.080
Why?
Infusions, Intravenous
1
1999
143
0.080
Why?
Aortitis
1
1997
1
0.080
Why?
Adolescent
1
2008
5044
0.080
Why?
Dyspnea
1
1997
13
0.080
Why?
Aneurysm, Infected
1
1997
11
0.080
Why?
Aortic Aneurysm, Thoracic
1
1997
17
0.080
Why?
Cough
1
1997
24
0.080
Why?
Proto-Oncogene Proteins
1
2000
301
0.080
Why?
Mice, Transgenic
1
2000
770
0.070
Why?
Brain
1
2005
1228
0.070
Why?
Heterogeneous-Nuclear Ribonucleoprotein D
1
1996
2
0.070
Why?
Streptococcus pyogenes
1
1997
103
0.070
Why?
Gene Expression
1
2000
764
0.070
Why?
Receptors, Adrenergic, beta
1
1996
67
0.070
Why?
Sodium
2
1993
306
0.070
Why?
Membrane Potentials
2
1993
343
0.070
Why?
Potassium
2
1993
309
0.070
Why?
Streptococcal Infections
1
1997
171
0.070
Why?
Chronic Disease
1
1997
554
0.070
Why?
Gramicidin
1
1994
2
0.060
Why?
Valinomycin
1
1994
15
0.060
Why?
RNA-Binding Proteins
1
1996
130
0.060
Why?
Postoperative Complications
1
1999
764
0.060
Why?
Ethoxzolamide
1
1993
2
0.060
Why?
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
1
1993
9
0.060
Why?
Apoptosis
1
2000
855
0.060
Why?
Carbocyanines
1
1993
20
0.060
Why?
Body Water
1
1993
33
0.060
Why?
Sucrose
1
1993
85
0.060
Why?
Saline Solution, Hypertonic
1
1993
29
0.060
Why?
Benzothiazoles
1
1993
52
0.060
Why?
Indicators and Reagents
1
1993
115
0.060
Why?
Osmolar Concentration
1
1993
159
0.060
Why?
Hemoglobins
1
1993
95
0.060
Why?
Scattering, Radiation
1
1993
77
0.060
Why?
Light
1
1993
157
0.050
Why?
Gene Expression Regulation
1
1996
895
0.050
Why?
Sleep Apnea Syndromes
1
2010
17
0.050
Why?
Hypertension, Pulmonary
1
2010
28
0.040
Why?
Esophagogastric Junction
1
2009
31
0.040
Why?
Endoscopy, Gastrointestinal
1
2009
28
0.040
Why?
Quality-Adjusted Life Years
1
2009
53
0.040
Why?
Sex Characteristics
1
2010
141
0.040
Why?
Catecholamines
1
2009
78
0.040
Why?
RNA, Messenger
1
1996
1893
0.040
Why?
Cost-Benefit Analysis
1
2009
215
0.040
Why?
Mice
1
2000
6206
0.040
Why?
Sensitivity and Specificity
1
2009
914
0.030
Why?
Tomography, X-Ray Computed
1
2009
785
0.030
Why?
Oxygen Consumption
1
2004
205
0.030
Why?
Polyribosomes
1
1996
18
0.020
Why?
Muscle, Smooth
1
1996
119
0.020
Why?
Ultraviolet Rays
1
1996
197
0.020
Why?
Intracellular Fluid
1
1994
42
0.020
Why?
DNA Primers
1
1996
422
0.020
Why?
Cell Membrane Permeability
1
1994
102
0.020
Why?
GTP-Binding Proteins
1
1996
146
0.020
Why?
Ion Transport
1
1994
70
0.020
Why?
Recombinant Proteins
1
1996
770
0.010
Why?
Base Sequence
1
1996
1721
0.010
Why?
Molecular Sequence Data
1
1996
2046
0.010
Why?
Signal Transduction
1
1996
1629
0.010
Why?

Visualizations


Bisognano's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department